CZJClass II
Igd, Antigen, Antiserum, Control
21 CFR 866.5510 / Immunology
CZJ is the FDA product code for Igd, Antigen, Antiserum, Control, a class II device type, regulated under 21 CFR 866.5510. As of , FDA records hold 8 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- CZJ
- Device name
- Igd, Antigen, Antiserum, Control
- Regulation
- 21 CFR 866.5510
- Device class
- Class II
- Review panel
- Immunology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 8
- Ingested recalls
- 0
Clearances, product code CZJ
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1978 | 1 |
| 1983 | 1 |
| 1987 | 1 |
| 1988 | 1 |
| 1991 | 1 |
| 2000 | 1 |
| 2005 | 1 |
| 2009 | 1 |
Applicants with the most clearances
Product code CZJ| Applicant | Clearances |
|---|---|
| The Binding Site | 4 |
| Helena Laboratories, Corp. | 1 |
| Hyland Therapeutic Div., Travenol Laboratories | 1 |
| Kallestad Diag, A Div. of Erbamont, Inc. | 1 |
| Kent Laboratories, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
